[ad_1] Elaine Gemmell, head of regulatory affairs at InnoScot Health, analyses where the new EU AI Act legislation is beneficial and where it must remain flexible. The EU agreeing a…
[ad_1] Elaine Gemmell, head of regulatory affairs at InnoScot Health, considers the latest MHRA initiative, the Innovative Devices Access Pathway (IDAP). The opening of applications for a pilot of the…
[ad_1] Head of Regulatory Affairs at InnoScot Health, Elaine Gemmell, believes greater resources must be deployed after three new UK Approved regulatory Bodies to certify medical devices were announced. The…
[ad_1] Elaine Gemmell, head of regulatory affairs at InnoScot Health, discusses what the new strategy means for the future of regulation and bringing new innovations to the market. The UK…